Author Archives: Øyvind

The Norwegian Directorate of Health comes for an inspection – be prepared

The Norwegian Directorate of Health has notified an audit pursuant to the Gene Technology Act at the Faculty of Medicine, 10-12 September this year. In preparation for the audit, research group leders must submit documentation by August 29 in accordance with the following points

  1. Ongoing projects that have been applied for approval according to GMO (Brief overview of ongoing work with GMOs)
  2. Overview of ongoing GMO projects that have not been applied for approval
  3. List of persons who can be interviewed during the audit
  4. Which rooms (Room number) are used for GMO work

Everyone should familiarise themselves with this page of the HSE Handbook: 4.4. Genetically modified organisms (GMOs) – HSE at K2 (uib.no)

For the daily work in the laboratory, there are four things you have to deal with:

  1. That laboratories and facilities are approved for work with GMOs.
  2. That there is a notification/approval for the work you are performing. The notification/approval must include a pre-assessment (risk assessment) of the contained use. A link to the notification form for GMM can be found here.
  3. That the work is carried out in a safe manner. Each research group should have its own procedures for this work, based on its own risk assessment.
  4. That a journal is kept of the work, and must be able to be presented in the event of an inspection.

For all activities involving GMOs, the principles of good microbiological practice and the following principles of good safety and hygiene in the workplace apply.

For questions, contact Siv Lise Bedringsaas (siv.bedringaas@uib.no)

New Deputy Director of Research

Professor Kurt Hanevik takes over as the new deputy director for research at K2. Kurt is a specialist in infectious diseases. He also has experience from international humanitarian aid and global health. He defended his thesis on research on the long-term effects of the Giardia epidemic in and has continued research on diarrhoea and related disorders. His experience and expertise will constitute a good addition to the leadership at K2.

Have a good weekend when the time comes!

Regards
Eystein Husebye

(Norsk) Status som merittert underviser – utlysning 2024

The Faculty of Medicine is inviting teaching staff to apply for the status of distinguished educator. Distinguished status is awarded to academic staff who have shown significant efforts to ensure educational quality in a broader sense. Academic staff in all position categories with teaching obligations can apply, except for doctoral candidates, postdocs, and specialist candidates. Individuals (not groups) can apply for distinguished status. To be considered, one must have been employed in a teaching position for at least five years and be able to document pedagogical basic competence.

More information can be found here: Meritteringsordning for fremragende undervisere ved Det medisinske fakultet | Enhet for læring | UiB

This year’s deadline is 01.11.24.

If you wish to apply or learn more, please contact the acting head of studies at martha.dahle@uib.no

Digital morning coffee with the rector

Dear all colleagues,

 The academic year is officially underway. On that occasion, I would like to welcome you to a new digital morning coffee to talk about what occupies the university leadership.Some of the topics will be the start of the semester and today’s student generation and UiB’s ambitions and challenges as an international university. 

It is also possible to submit questions in advance via this form. https://skjemaker.app.uib.no/view.php?id=17537491

The morning coffee takes place on Thursday 29 August at 09:00-09:30 on Zoom. Follow the link to participate: https://uib.zoom.us/j/64244074872?pwd=zBvwesafx5KROfaisebI5HjMzeaEKb.1

 The conversation is in Norwegian.

 Kind regards

Margareth Hagen, rector

Welcome to Mohn Synergy Symposium, on August 29

In 2024, the Trond Mohn Research Foundation (TMF) celebrates its 20th anniversary, marking two decades of significant contributions to research in Bergen and beyond. This milestone coincides with the co-location of researchers from three prominent Mohn Research Centers on the 7th floor of the University of Bergen’s BBB research building, where the new Bergen Center for Medical Stem Cell Research is being established.

To explore opportunities for collaboration between these three research centers, which all have common interests in neuroscience, stem cells, and cell biology, we are excited to organize the first Mohn Synergy Symposium on Thursday, August 29. Here, we will delve into common research interests and supplemental methodological approaches while honoring TMF’s contribution to scientific initiatives and progress.

The event is open to all, and no registration is required. Welcome!

Link to event: Mohn Synergy Symposium 2024 – Helse Bergen HF (helse-bergen.no)

More about the three Mohn Research Centres:

  1. Mohn Research Center for Regenerative Medicine (MRCRM), led by Professor Einar Kristoffersen ( https://www.helse-bergen.no/en/regenerative-medicine/)
  2. Mohn Research Center for Psychotic Disorders (MRCP), led by Professor Erik Johnsen ( https://www.helse-bergen.no/en/regenerative-medicine/mohn-research-centre-for-psychotic-disorders/)
  3. Mohn Research Center for the Brain (MRCB), led by Professor Clive Bramham with Nobel Laureate Professor Edvard Moser as co-lead (https://www.ntnu.edu/kavli/mohn-research-center-for-the-brain)